Novo Nordisk produces a wide range of products within the different therapy areas. See a total list of our products.
These images are downloadable for non-commercial use and for purposes such as news reporting or research related to Novo Nordisk. If you have comments or questions, please do not hesitate to contact us.
NovoPen®is the latest innovation in durable insulin delivery devices from Novo Nordisk. NovoPen® 5 is a durable pen based on the design of NovoPen® 4, but with an added easy-to-use memory function.
NovoPen® 4 is a durable insulin pen which allows patients to change their insulin cartridge whilst retaining the same pen. 2010 is the 25th anniversary for NovoPen® which was the first insulin pen ever produced.
Insulin pen specifically designed to meet the needs of children with diabetes. First ever insulin pen to offer a combination of a memory function with a half-unit dosing option. Will be launched in 2010.
An additional feature of the NovoPen® Echo is the option of customising the look of the pen with a number of colourful skins. Will be launched in 2010.
New needle designed for use with the insulin delivery device FlexPen® and Victoza® Pen. The needle, which has a simple ‘just twist’ attachment and detachment, makes injection easier for people with diabetes
NovoFine® Autocover® was the world's first safety pen needle, designed to help prevent accidental needlestick injuries.
(Zinc# HQMMA/NR/1014/0187b date of approval: October 2014)
The next generation of NordiFlex®represents the latest advance in prefilled growth hormone pens from Novo Nordisk.
FlexTouch® is the latest prefilled device from Novo Nordisk; the only prefilled insulin pen with no push-button extension
NordiFlex PenMate® with automatic needle insertion accessory for users of NordiFlex® who prefer a hidden needle when injecting.
With human growth hormone for treatment of growth disorders.
NordiPen® with human growth hormone for treatment of growth disorders.